S&P 500 Consumer Discretionary Sector SEC Filings — May 14, 2026

14-05-2026

HARBERT FUND ADVISORS, INC. filed a 13F-HR on May 14, 2026, reporting holdings as of March 31, 2026. The filing discloses sole voting authority over 735,768 shares of Identiv Inc. common stock and 92,927 shares of Transact Technologies Inc. common stock. No prior period comparisons, changes, or additional holdings are detailed.

• · Filing accession number: 0000919574-26-003023
• · SEC file number: 028-16265
• · Company address: 2100 Third Avenue North, Suite 600, Birmingham, AL 35203

14-05-2026

On May 12, 2026, the Board of Directors of First Real Estate Investment Trust of New Jersey, Inc. (FREIT) unanimously approved a Plan of Voluntary Liquidation, subject to shareholder approval at a special meeting expected in Fall 2026, authorizing the sale of all assets and potential transfer to a liquidating trust. On May 13, 2026, FREIT entered into a Third Amendment to its Management Agreement with Hekemian & Co., specifying termination fees of 2.5x the average annual Base Management Fee over the prior three years (pro rata) and a 1.65% sales fee on dispositions. To incentivize timely sales, CEO Robert S. Hekemian, Jr. is eligible for a $1M bonus if all properties are sold or contracted within 18 months post-approval with gross proceeds exceeding $319.9M and closings completed.

• · Plan effectiveness requires affirmative vote of majority of Common Stock holders entitled to vote.
• · Upon Plan effectiveness, no further shareholder approval needed for asset sales or dispositions.
• · Board may transfer remaining assets to a Liquidating Trust and distribute beneficial interests in kind to stockholders.

14-05-2026

14-05-2026

14-05-2026

14-05-2026

First Tracks Biotherapeutics launched on April 20, 2026, with $180 million in cash providing a two-year runway to advance ANB033 through Phase 1b data readouts in Q4 2026 (celiac disease) and mid-2027 (eosinophilic esophagitis). For Q1 2026 (pre-separation combined results), R&D expenses decreased 18% YoY to $34.0 million due to lower rosnilimab and ANB032 costs, but G&A expenses more than doubled to $18.9 million driven by separation-related legal and stock compensation costs, resulting in a widened net loss of $50.5 million (up 7% YoY from $47.2 million). Cash and equivalents stood at $248.5 million as of March 31, 2026, up from $238.2 million at year-end 2025.

• · Separation from AnaptysBio completed April 20, 2026; Q1 financials include allocated expenses from both entities.
• · Completed End-of-Phase 2 meeting with FDA for rosnilimab in Q1 2026; assessing strategic options including partnerships for RA development.
• · ANB101 Phase 1a trial in healthy volunteers nearing completion.
• · Total current assets $289.4M as of March 31, 2026 (down from $316.4M at Dec 31, 2025).

14-05-2026

Fortress Biotech reported consolidated net income attributable to common stockholders of $108.4 million, or $3.44 per basic share ($2.82 diluted), for Q1 2026, compared to a $12.7 million net loss in Q1 2025, primarily driven by $205 million gross proceeds from Cyprium Therapeutics' sale of its Rare Pediatric Disease Priority Review Voucher following ZYCUBO® FDA approval. Consolidated net revenue grew 22% YoY to $16.0 million, with Journey Medical contributing $15.9 million from dermatology products (up from $13.1 million), and cash and cash equivalents increased to $255.8 million from $79.4 million at year-end 2025 after debt prepayments reducing Oaktree loan principal to $15.0 million. However, AstraZeneca's anselamimab (CAEL-101) did not meet the primary Phase 3 CARES endpoint, despite positive subgroup data and planned regulatory submissions.

• · Cyprium eligible for tiered royalties on ZYCUBO net sales and up to $128 million in sales milestones from Sentynl.
• · Fortress received ~$28 million upfront from Checkpoint acquisition by Sun Pharma, with potential $4.8 million CVR and 2.5% royalty on UNLOXCYT net sales.
• · Journey Medical expanded payer access for Emrosi to over 150 million commercial lives (85% of U.S. commercial lives) as of April 1, 2026.
• · Consolidated R&D expenses declined to $0.5 million in Q1 2026 from $3.9 million in Q1 2025.
• · Cyprium redeemed all outstanding shares of its 9.375% Perpetual Preferred Stock in connection with PRV sale.

14-05-2026

14-05-2026

Newton Golf reported Q1 2026 net sales of $991,000, down 18% YoY from $1.2 million due to manufacturing transition delays, with gross profit at $628,000 (63% margin) versus $852,000 (70%) prior year and operating expenses up 15% to $3.2 million, resulting in a net loss of $2.7 million ($0.58/share) compared to $0.5 million ($0.55/share). Positively, DTC customer deposits and open wholesale orders totaled $1.2 million in expected future revenue, returning customer orders rose 47% to 1,253, and the company raised $1.35 million via convertible notes. Operational highlights include new product introductions, a South Korea distribution deal, and professional club fitter network expansion to 235 accounts (+99% YoY).

• · Convertible notes: up to $2.0 million total, with fixed conversion price $1.60 and warrants at $1.75/share; 10% interest, 18-month maturity.
• · Guinness World Record: Fast Motion shaft achieved 235.1 mph ball speed by Thomas Fliniks.
• · Exclusive distribution agreement with VC Inc. for South Korea.
• · New hires: East Coast sales manager (secured 30 new accounts), head of manufacturing (20+ years experience).
• · Conference call: May 14, 2026, 4:30 p.m. ET.

14-05-2026

14-05-2026

14-05-2026

14-05-2026

14-05-2026

14-05-2026

Marine Petroleum Trust reported total assets of $940,643 as of March 31, 2026, up 2.1% from $921,527 as of June 30, 2025, primarily due to higher cash and cash equivalents of $940,636 (vs. $921,520). However, producing oil and natural gas properties remained flat at $7, and there were no current liabilities or federal income tax payable in either period. The trust corpus matched total assets at $940,643.

• · Filing date: May 14, 2026
• · No federal income tax refundable or payable reported in either period
• · Trust corpus equals total assets in both periods

14-05-2026

Forgent Power Solutions reported fiscal Q3 2026 revenues of $379 million, up 103% YoY from $186 million, with record bookings of $867 million (up 308% YoY) and backlog of $1.98 billion (up 157% YoY and 33% QoQ). Net income increased 190% YoY to $24 million (6.5% margin, up ~650 bps QoQ), Adjusted EBITDA rose 96% to $85 million (22.4% margin, up ~200 bps QoQ), and cash flow from operations improved to $29 million. The company raised FY2026 guidance to $1,350-$1,390 million revenue (82% YoY midpoint), $310-$320 million Adjusted EBITDA (86% YoY), and $197-$207 million Adjusted Net Income (128% YoY), though margins were modestly impacted by under-absorbed labor/overhead costs and startup expenses at new facilities (1.8% of revenues vs. 2.0% prior quarter).

• · Book-to-bill ratio of 2.3x in Q3 FY2026 vs. 1.1x in prior year quarter
• · Q4 FY2026 revenue guidance: $392-$432 million
• · Q4 FY2026 Adjusted EBITDA guidance: $100-$110 million
• · Expected capacity post-expansion to support up to $5 billion annual revenues
• · Conference call on May 14, 2026 at 11:00 a.m. Eastern Time

14-05-2026

DC Funds, LP filed its 13F-HR on May 14, 2026, disclosing equity holdings as of March 31, 2026, with a total portfolio market value of $1,485,900 across 3 positions, all held with sole voting power. Key holdings include Barinthus Biotherapeutics plc ADS (642,204 shares valued at $365,414), TScan Therapeutics Inc common stock (630,000 shares valued at $630,000), and Werewolf Therapeutics Inc common stock (589,102 shares valued at $490,486). No prior period comparisons are provided in the filing.

• · Period end date: March 31, 2026
• · Barinthus Biotherapeutics: 642,204 shares sole
• · TScan Therapeutics: 630,000 shares sole
• · Werewolf Therapeutics: 589,102 shares sole

14-05-2026

Lifeway Foods reported record Q1 2026 net sales of $63.0 million, up 36.7% YoY from $46.1 million, driven by 37% volume-led growth in Lifeway Kefir and Farmer Cheese, with gross profit margin expanding 360 basis points to 27.5%. Net income rose 32% to $4.7 million ($0.30 diluted EPS), reflecting operational execution, though SG&A expenses increased 16.8% to $10.9 million amid marketing investments. The company drew $6.9 million on its line of credit to fund $11.0 million in capex, supporting growth outlook including $45-50 million Adjusted EBITDA target for FY2027.

• · Total assets increased to $120.5 million as of March 31, 2026 from $105.6 million at December 31, 2025.
• · Property, plant and equipment, net rose to $57.8 million from $48.3 million QoQ due to capex.
• · Net cash provided by operating activities was $4.4 million in Q1 2026 vs used $0.2 million in Q1 2025.
• · 26th consecutive quarter of year-over-year net sales growth.
• · Recognized as Dairy Foods' Processor of the Year 2025 and other awards.

14-05-2026

Wayfair Inc. issued a press release on May 13, 2026, announcing the pricing by its subsidiary Wayfair LLC of a private offering of $400 million aggregate principal amount of 7.125% senior secured notes due 2034. The notes are being offered only to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S, and have not been registered under the Securities Act. There is no assurance that the issuance and sale will be consummated.

• · Notes and related guarantees not registered under the Securities Act of 1933
• · Offered only to persons reasonably believed to be qualified institutional buyers (Rule 144A) and non-U.S. persons (Regulation S)
• · Information in Item 7.01 and Exhibit 99.1 not deemed 'filed' under Section 18 of the Exchange Act

14-05-2026

FingerMotion, Inc., a Delaware corporation with operations in Singapore, entered into a Securities Purchase Agreement dated May 13, 2026, with certain buyers to issue and sell Notes in a private placement pursuant to Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. The Closing is scheduled for no later than the second Business Day after execution, subject to satisfaction of conditions. The agreement includes representations confirming no material adverse effects since the latest financial statements, compliance with laws, valid intellectual property, adequate insurance, and no undisclosed liabilities or litigation with material impact.

• · Commission payable to Weild & Co for the transaction.
• · No brokerage or finder's fees payable to others.
• · Company address: 111 Somerset Road, Level 3, Singapore.

14-05-2026

New Fortress Energy Inc. reported total revenues of $226,953 thousand for the three months ended March 31, 2026, down 52% YoY from $472,282 thousand, leading to a sharply wider operating loss of $(225,375) thousand and net loss of $(400,604) thousand (EPS $(1.40)) compared to $(175,426) thousand (EPS $(0.65)) in Q1 2025, driven by declines across revenue streams and spikes in transaction costs (+346%) and asset impairments. Operating cash use worsened to $(118,902) thousand from $(7,237) thousand, with cash and equivalents plus restricted cash falling to $189,881 thousand. However, the company holds a $10,304,872 thousand revenue backlog extending through 2030 and beyond.

• · Asset impairment expense surged to $61,864 thousand in Q1 2026 from $246 thousand YoY.
• · Cash, cash equivalents and restricted cash decreased by $167,061 thousand during Q1 2026.
• · Contract assets, net decreased to $20,113 thousand as of March 31, 2026 from $32,166 thousand at Dec 31, 2025.

14-05-2026

BGSF, Inc.'s amended 10-Q for the thirteen weeks ended March 29, 2026 (Q1 2026) shows a stable ending allowance for credit losses at $1,156 thousand, up 15.6% YoY from $1,000 thousand, with provision expense down significantly to $96 thousand from $198 thousand. However, amounts written off increased to $130 thousand from $112 thousand, total receivables declined to $1,313 thousand from $1,458 thousand QoQ, and computer software amortization expense dropped to $133 thousand from $299 thousand YoY. Weighted-average common shares outstanding decreased slightly to 10,684 thousand from 10,954 thousand YoY.

• · CARES Act receivable reduced to $0 from $280 thousand QoQ.
• · Weighted average remaining contractual life of options decreased to 5.0 years from 5.2 years.
• · Total intrinsic value of options outstanding increased to $124 thousand from $52 thousand.

14-05-2026

For the six months ended March 31, 2026, Oaktree Strategic Credit Fund reported total investment income of $364,495, up 27.4% YoY from $286,237, and net investment income of $198,605, up 32.9% YoY from $149,459, driven by higher interest and fee income. However, net unrealized depreciation of $110,156 and realized losses of $21,487 led to a 48.4% YoY decline in net increase from operations to $66,953, resulting in total net assets falling 3.1% to $4,402,669 from $4,541,805 at September 30, 2025, with NAV per share dropping to $22.38 from $23.09. The three months ended March 31, 2026 saw a net decrease in net assets from operations of $10,065 versus a $52,900 gain YoY, amid significant share repurchases totaling over $500,000 net across classes.

• · Net cash used in operating activities was $261,995 for six months ended March 31, 2026, less negative than $959,824 YoY.
• · Share repurchases net: Class I ($332,019), Class S ($169,360) for six months ended March 31, 2026.
• · Credit facilities borrowings $990,600 offset by repayments $877,000 in financing activities.
• · Total liabilities increased 10.3% to $3,022,784 from $2,740,629.

14-05-2026

Fermi Inc. (FRMI) filed an 8-K on May 14, 2026 (Items 5.03, 9.01), disclosing its Amended and Restated Bylaws effective May 13, 2026. The bylaws establish standard governance provisions including shareholder meeting procedures (quorum at majority of shares, 10-60 days notice), board powers, officer roles, indemnification, and amendment processes under Texas law. No financial metrics, material changes, or performance impacts are referenced.

• · Shareholder meetings held in Amarillo, Texas, or remotely per TBOC Section 6.002(a)
• · Quorum requires holders of majority of voting shares present or by proxy
• · Notice periods: 10-60 days generally; 21 days minimum for fundamental business transactions
• · No cumulative voting for directors; actions by written consent require unanimous approval
• · Governed by Texas Business Organizations Code (TBOC)

14-05-2026

First International Bank of Israel Ltd., a subsidiary of F.I.B.I. Holdings Ltd., filed its 13F-HR on May 14, 2026, disclosing 59 U.S.-listed equity holdings as of March 31, 2026, primarily consisting of ETFs and select large-cap stocks. Significant positions include $38.2M in FIRST TR EXCHNG TRADED FD VI FT VEST US EQT (CUSIP 33740U679) and $28.9M in FIRST TR EXCHNG TRADED FD VI FT VEST US (CUSIP 33740F631), alongside stocks like Amazon.com Inc. ($5.6M) and Apple Inc. ($2.3M). The Bank manages these directly, through subsidiaries, or via HaBeinleumi Unique Portfolio Management Ltd. for clients, disclaiming any control group with its parent.

• · Securities reported are beneficially owned by the Bank, subsidiaries, or purchased by Unique on behalf of clients with investment discretion.
• · Filer and parent F.I.B.I. Holdings Ltd. operate under independent management with separate voting and investment decisions.
• · Includes only dual-listed securities on U.S. and Tel Aviv exchanges that were purchased in the U.S., per SEC guidance.
• · Business address: 42 Rothschild Blvd, Tel Aviv, L3 6688310, Israel

14-05-2026

Nan Shan Life Insurance Co., Ltd. disclosed 87 equity positions totaling $2,762,183,209 in its 13F-HR filing as of March 31, 2026. Top holdings include Alphabet Inc. Cap Stk Cl A at $172,459,221, Apple Inc. at $109,586,014, Microsoft Corp. at $100,923,889, and NVIDIA Corporation at $89,760,366, with all positions held solely. The portfolio spans technology giants, ETFs, healthcare, and energy stocks with no reported changes or performance metrics.

• · Filing date: May 14, 2026
• · Report period end: March 31, 2026
• · All 87 positions held with sole voting discretion
• · Portfolio includes ETFs such as iShares Core MSCI Emerging Markets ETF (456,506 shares, $31,841,294) and Invesco QQQ Trust (135,377 shares, $78,136,897)

14-05-2026

For the three months ended March 31, 2026, revenues surged 321% YoY to $188,756 driven by retail trading revenue of $182,278 (up 307% YoY), with gross profit rising 200% YoY to $59,068. However, selling, general and administrative expenses ballooned to $161,140 (over 1,169% increase YoY), leading to an operating loss of $102,072 versus a $6,994 profit in Q1 2025, and net cash used in operations widened to $71,811. Cash and equivalents fell sharply 78% QoQ to $15,332 from $68,888, while total stockholders' equity plummeted 90% QoQ to $11,427 from $113,391.

• · Amount due to related party increased to $110,610 as of March 31, 2026 from $78,260 as of Dec 31, 2025.
• · Amount due to a director rose to $21,188 as of March 31, 2026 from $15,565 as of Dec 31, 2025.
• · Net cash used in operating activities was $71,811 in Q1 2026 vs $4,832 in Q1 2025.
• · Right-of-use assets include $27,840 from related party as of March 31, 2026.

14-05-2026

Sumitomo Mitsui Financial Group, Inc. filed its 13F-HR on May 14, 2026, disclosing institutional holdings as of March 31, 2026, across subsidiaries including Sumitomo Mitsui Banking Corporation and SMBC Nikko Securities Inc. The portfolio features large positions such as Ares Management Corporation ($1.458B), Jefferies Financial Group Inc. ($382M), SPDR Gold Trust ($254M), and Polestar Automotive ($190M), alongside ETFs and tech stocks like NVIDIA ($82M). No prior period data is provided for comparisons, with holdings including both common shares and options.

• · Filing period end date: March 31, 2026
• · Includes positions in call and put options on stocks like Uber Technologies, Qualcomm, and Verizon
• · Portfolio managed under multiple CIK numbers including 028-17794, 028-17800, 028-18879

14-05-2026

CubeSmart presented its New York City self-storage portfolio as of March 31, 2026, highlighting its market-leading position with 46 owned and 19 managed properties across NYC boroughs (total 65), including top rankings in Brooklyn (23 total), Queens (21 total), and Bronx (16 total). The portfolio extends to suburbs with 82 owned and 46 managed properties across Northern NJ, Long Island, and Westchester (total 128). Attractive market dynamics feature low supply per capita (2.6-3.3 sq ft) and positive SF per capita CAGRs of 2.3-3.4% from 2014-2025, with no noted declines.

• · Brooklyn density: 38,424 per sq mi; Queens: 21,694 per sq mi; Bronx: 33,325 per sq mi
• · Brooklyn sq ft per capita: 2.6; Queens: 2.6; Bronx: 3.3
• · Key Brooklyn submarkets: Coney Island, Gowanus, East NY, Atlantic Ave Corridor
• · Key Queens submarkets: Ridgewood, Jamaica, Long Island City, Astoria, College Point/Flushing, Bellerose
• · Key Bronx submarkets: South Bronx, Bronx River/Bruckner, Riverdale/Kingsbridge, Co-Op City
• · Portfolio diversified across seven submarkets in NY MSA

14-05-2026

Larimar Therapeutics reported a Q1 2026 net loss of $29.6 million, slightly up from $29.3 million in Q1 2025, driven by R&D expenses decreasing to $25.0 million from $26.6 million but offset by G&A expenses rising to $6.1 million from $4.6 million. Cash, cash equivalents, and marketable securities stood at $200.4 million as of March 31, 2026, bolstered by $107.6 million net proceeds from a February public offering, extending runway into Q2 2027. The company progressed nomlabofusp development with plans for rolling BLA submission starting June 2026, topline open-label study data in Q2 2026, and global Phase 3 initiation mid-2026.

• · Net loss per common share improved to $(0.31) in Q1 2026 from $(0.46) in Q1 2025.
• · Total assets $208.5 million as of March 31, 2026 vs $145.8 million as of December 31, 2025.
• · Breakthrough Therapy Designation granted by FDA in February 2026 for nomlabofusp.

14-05-2026

Hyperion DeFi reported record Q1 2026 GAAP Net Income of $8,840,550 and Non-GAAP Adjusted EBITDA of $19,488,132, with Adjusted Gross Profit up 17% QoQ to $959,568 driven by DeFi Monetization (+140% to $245k) and Yield Enhancement (+165% to $211k), alongside treasury growth to 1.94M Gross HYPE Tokens ($71.0M holdings) at quarter-end and over 2.00M as of May 11. However, Ecosystem Rewards declined 47% QoQ to $150k, Validator Commissions fell 17% to $40k, Staking Yield was up only 2% to $313k (flat), and operating activities used $4.2M net cash. The company raised FY2026 Adjusted Gross Profit guidance by ~20% to $5M-$7M (~5x FY2025 actuals).

• · Net Cash Used in Operating Activities: $4.2M in Q1 2026 (would be $2.7M excluding $1.5M net increase in operating assets)
• · Cash, Cash Equivalents, and USDH: $9.1M end Q1 2026, $16.0M as of May 11, 2026
• · Net Cash Used in Investing Activities for HYPE purchases: $1.5M Q1 2026; additional $2.5M QTD Q2'26 to May 11
• · Net Cash Provided by Financing Activities: $6.6M Q1 2026; additional $1.9M QTD Q2'26 to May 11 from ATM offering; $8.7M from May 7 public offering of 2,777,778 shares
• · Earnings conference call: May 14, 2026 at 8:00 a.m. Eastern Time

14-05-2026

WhiteFiber reported total revenues of $21,923,451 for Q1 2026, up 30.7% YoY to $21.9M driven by strong colocation growth (+190.3%) and cloud services (+13.0%), with total assets expanding 22.3% QoQ to $796,297,355. However, sharply higher operating expenses, particularly G&A at $17,770,097 (up over 4x YoY), led to an operating loss of $11,019,824 and net loss of $12,042,404 versus Q1 2025 profit of $1,427,836; shareholders' equity fell 27.0% QoQ to $352,579,430 amid $169,168,417 in capex and new $222,308,429 convertible notes. Cash from operations turned positive at $3,228,873 (vs -$2,933,953 YoY), but cash equivalents dropped 33.8% QoQ to $75,782,755.

• · Issued $222,118,088 net proceeds from convertible debt in Q1 2026.
• · Purchased zero-strike call option for $119,999,984 related to convertible notes.
• · Proceeds from disposal of property and equipment: $26,082,000 in Q1 2026.
• · Share-based compensation expenses: $7,317,401 in Q1 2026 cash flow.
• · Deferred revenue increased significantly to $144,507,575 total (current + non-current) from $79,551,452 QoQ.

14-05-2026

Burford Capital Limited held its 2026 AGM on May 13, 2026, with 152,939,775 Ordinary Shares voted, representing 70.02% of the 218,422,440 shares outstanding as of the March 16, 2026 record date. All resolutions 1-16 passed the requisite majorities, including director re-elections (84.78%-96.90% approval), a 6.25¢ final dividend per Ordinary Share payable June 12, 2026, auditor reappointment at 99.89%, and advisory Say-on-Pay approval at 72.92%. However, notable opposition included 15.21% against John Sievwright's re-election and 27.07% against Say-on-Pay.

• · Proxy statement filed April 2, 2026.
• · Dividend payable June 12, 2026 to shareholders on register at close of business May 22, 2026.
• · Resolutions 15 and 16 passed with no less than 75% votes cast.
• · Broker non-votes: 16,849,782 for applicable resolutions.

14-05-2026

Merlin, Inc. reported Q1 2026 revenue of $1.0 million, up slightly 15% YoY from $0.9 million, driven by early operations post its March 16, 2026 business combination with Inflection Point Acquisition Corp. IV. However, GAAP net loss widened significantly to $(90.4) million from $(12.7) million YoY, and Adjusted EBITDA loss increased to $(23.3) million from $(10.4) million, reflecting merger-related and operating costs. Business highlights include first automated takeoffs, Condor product introduction, C-130J $105 million contract progress, and cash position of $183 million post May 1 equity financing.

• · Executed first fully automated takeoffs on fixed-wing aircraft on April 11, 2026 (US) and April 21, 2026 (New Zealand).
• · Michael Baker joined as CMO effective March 31, 2026; Mark Brunner as CRO effective April 13, 2026.
• · Memorandum of understanding with World Star Aviation Limited for Condor commercial development (preliminary, non-binding).

14-05-2026

Fosun International Ltd filed its 13F-HR on May 14, 2026, disclosing 66 equity holdings totaling $398585897 as of March 31, 2026. Largest positions include Lanvin Group Holdings Limited ($136404665), Chagee Hldgs Ltd ($86163076), and Butterfly Network Inc ($43295185), with significant allocations also to KKR & Co Inc preferred ($20391540) and DBX ETF ($16981613). The portfolio features US tech names like Alphabet Inc ($3652587), Microsoft Corp ($3513283), and NVIDIA Corp ($2604664), alongside Chinese ADRs, ETFs, and notes, but no period-over-period changes are reported.

• · Filing period end date: March 31, 2026
• · Report includes mix of common stocks, preferred shares, ETFs, and notes
• · Additional notable holdings: Quantum SI Inc (743935 shares, $575806), Hyperfine Inc (1742020 shares, $1881382)

14-05-2026

Syncona Portfolio Ltd filed a 13F-HR on May 14, 2026, reporting holdings as of March 31, 2026, in Autolus Therapeutics PLC Sponsored ADS (16,640,720 shares valued at $22,964,194) and Century Therapeutics common stock (1,213,056 shares valued at $2,741,507). The securities are owned directly by Syncona Portfolio Limited and indirectly by Syncona Portfolio Holdings LP, Syncona Holdings Limited, Syncona Limited, and Syncona Investment Management Limited, with investment decisions guided by an investment committee of Roel Bulthuis, Christopher Hollowood, and Kenneth Galbraith. No prior period comparisons are provided in the filing.

• · Filing period end date: March 31, 2026
• · CUSIP for Autolus Therapeutics PLC Sponsored ADS: 05280R100
• · CUSIP for Century Therapeutics common stock: 15673T100
• · Manager discretion for both holdings: OTR (Other) with managers 1,2,3,4

14-05-2026

Novak & Powell Financial Services, Inc. filed its 13F-HR report on May 14, 2026, disclosing 164 equity holdings totaling $185626233 as of March 31, 2026, all held with sole voting authority. The portfolio is diversified across individual stocks and ETFs, with top positions including Vanguard Growth ETF (25831 shares valued at $11282635), Apple Inc. (38991 shares valued at $9895505), and Vanguard Large-Cap ETF (28637 shares valued at $8558279). No other voting authority or discretion is reported.

• · Report period end: March 31, 2026
• · All 164 positions held as sole voting authority (SH SOLE)
• · No shared or other voting authority reported

14-05-2026

For Q1 2026, FitLife Brands reported revenue of $25,325, up 59% YoY from $15,936, driven by the addition of $12,849 from Irwin, though Legacy FitLife revenue declined 22% YoY to $12,476. Operating income rose modestly 3% YoY to $3,061, but net income fell 15% YoY to $1,720 amid higher interest expense. Total assets decreased to $104,269 from $106,320 QoQ, with cash dropping 28% QoQ to $1,192, while stockholders' equity increased 4% QoQ to $45,381.

• · Revolving line of credit balance: $4,200 as of March 31, 2026 (down from $5,600 QoQ)
• · Term loan total: $37,428 ($6,094 current + $31,334 long-term) as of March 31, 2026
• · Interest expense: $735 in Q1 2026 (up from $218 YoY)
• · Inventories net: $21,528 as of March 31, 2026 (slight increase from $21,324 QoQ)
• · Basic EPS: $0.18 in Q1 2026 (down from $0.22 YoY)

14-05-2026

Non Invasive Monitoring Systems Inc (NIMU) reported a Q1 2026 net loss of $163 thousand, more than quadrupling from $39 thousand in Q1 2025, due to sharply higher general and administrative expenses of $144 thousand versus $23 thousand YoY, with no revenue generated. Cash improved to $24 thousand from $6 thousand QoQ (December 31, 2025), driven by $100 thousand in proceeds from related party notes payable, resulting in a net cash increase of $18 thousand. However, total liabilities rose 18.5% QoQ to $1,185 thousand, and shareholders' deficit widened to $1,159 thousand from $996 thousand.

• · No revenue reported for Q1 2026 or Q1 2025
• · Notes payable to related parties increased to $720 thousand from $620 thousand QoQ
• · Accrued interest to related parties increased to $209 thousand from $189 thousand QoQ
• · Basic and diluted loss per common share: $(0.00) for both Q1 2026 and Q1 2025

14-05-2026

Marnell Management LLC reported a portfolio of 72 equity positions totaling $287516986 as of March 31, 2026, in its quarterly 13F-HR filing submitted on May 14, 2026. Holdings are concentrated in shipping and maritime stocks (e.g., Star Bulk Carriers Corp at $9883578 for 430282 shares, Ardmore Shipping Corp at $4565194 for 299357 shares), cryptocurrency mining firms (e.g., Terawulf Inc at $9909976 for 686762 shares, CleanSpark Inc at $2164740 for 254376 shares), and protective put options on major ETFs (SPDR S&P 500 ETF at $84544200 for 130000 units, iShares iBoxx High Yield ETF at $19890000 for 250000 units). No performance changes or returns are disclosed in this snapshot filing.

• · Significant call option positions include DHT Holdings Inc ($4932900 for 270000 shares), Hafnia Ltd ($2279240 for 299900 shares), and TORM PLC ($5172660 for 185400 shares).
• · Portfolio features exposure to metals/mining (e.g., Cleveland-Cliffs Inc 39613 shares at $334730), bitcoin miners (e.g., Core Scientific Inc 170476 shares at $2550321), and REITs (e.g., JBG Smith PPTYS 451873 shares at $6601865).

14-05-2026

Fivespan Partners, LP filed Form 13F-HR on May 14, 2026, disclosing its equity holdings as of March 31, 2026. The institutional investment manager reports sole discretionary authority over 4 securities with a total market value of $377,370,434,000. Holdings include Appian Corp Cl A (351,090,700 shares), Blackline Inc Com (301,394,300 shares), Outfront Media Inc Com New (277,469,000 shares), and Qiagen NV Ord Shares (268,924,300 shares).

• · Filer CIK: 0002040262
• · SEC File Number: 028-26316
• · Business address: 1170 Gorgas Avenue, San Francisco, CA 94129

14-05-2026

For the quarter ended March 31, 2026, the fund's net assets surged 77.5% QoQ to $81,952, driven by $34,205 in unit issuance proceeds and net realized/unrealized gains of $3,809, with investments growing 63.8% to $73,576. However, the fund incurred a net investment loss of $2,184 as total expenses of $2,408 exceeded investment income of $176, and cash flows from operations showed net usage of $31,159 primarily due to $25,685 in investment purchases. Total assets reached $90,327, up from $59,046, while liabilities declined 35% to $8,375.

• · Fund inception date: February 11, 2025
• · Investments primarily Level III valued at $60,001 (81.5% of total investments) as of March 31, 2026
• · Net cash used in operating activities: $31,159 for the quarter
• · Management fees waived: $48

14-05-2026

14-05-2026

William E. Oberndorf filed its 13F-HR for the quarter ended March 31, 2026, on May 14, 2026, disclosing seven holdings with a total portfolio value of approximately $500 million. Largest position is Sprott Physical Gold Trust with 7,954,118 units valued at $224 million, followed by Atlassian Corporation (4,821,522 shares at $71 million) and Guidewire Software (9,235,479 shares at $62 million). Other holdings include Amazon.com (7,504,176 shares at $36 million), Veeva Systems (7,931,576 shares at $45 million), UnitedHealth Group (9,620,287 shares at $36 million), and Autodesk (6,277,068 shares at $26 million).

• · All holdings reported as sole investment discretion and sole voting authority.
• · Signed pursuant to a Power of Attorney dated August 28, 2024.
• · Filer address: 615 Front Street, San Francisco, CA 94111.

14-05-2026

Broadleaf Partners, LLC reported total holdings of $428893859 across 84 positions in its 13F-HR filing as of March 31, 2026. The portfolio features significant allocations to technology leaders including Nvidia Corp (31746382 value), Apple Inc (23171535), Alphabet Inc Class C (23035719), Microsoft Corp (21991800), and Amazon.com Inc (21888136), alongside various Schwab ETFs such as Schwab US Large Cap Growth ETF (9150986). No prior period data is available in the filing for comparison.

• · Filing date: May 14, 2026
• · Report period end: March 31, 2026
• · Business address: 9 Aurora Street, Suite 5, Hudson, OH 44236
• · All holdings reported as sole voting authority

14-05-2026

Finepoint Capital LP filed its 13F-HR on May 14, 2026, disclosing total holdings valued at $1,952,510,884 as of March 31, 2026. Major positions include put options on SPDR S&P 500 ETF TR ($685,913,598), iShares TR iShares Semiconductor ($483,119,683), and Invesco QQQ TR ($366,367,891), reflecting significant bearish exposure to broad market and tech/semiconductor indices. Long equity stakes feature QXO Inc COM NEW ($269,130,419 for 13,858,415 shares) and RXO Inc ($147,276,295 for 10,073,618 shares), with smaller positions in Aleanna Inc, Calidi Biotherapeutics, and MoneyHero Limited warrants.

• · Aleanna Inc COM CL A: $229,774 value, 27,717 shares sole
• · Aleanna Inc *W EXP 12/13/202: $396,900 value, 490,000 shares sole
• · Calidi Biotherapeutics Inc COM: $249 value, 1,042 shares sole
• · MoneyHero Limited *W EXP 09/13/202: $76,075 value, 895,000 shares sole
• · Finepoint Capital LP based in Boston, MA; CIK 0001608126

14-05-2026

Swiss Life Asset Management Ltd filed its 13F-HR on May 14, 2026, disclosing 1,968 equity security holdings as of March 31, 2026, with a total market value of $20,422,601,436. Key positions include Alphabet Inc. CAP STK CL A (607,271,221 thousand USD sole), Apple Inc. COM (960,793,868 thousand USD sole), Amazon.com Inc. COM (427,673,281 thousand USD sole), and Alphabet Inc. CAP STK CL C (446,211,304 thousand USD sole). The report lists holdings across SOLE and DFND voting authority, with Swiss Life Asset Managers France as an other manager.

• · Filing CIK: 0001637689
• · SEC File Number: 028-25895
• · Business address: General Guisan-quai 40, Zurich V8 8002
• · Report period end: 03-31-2026